Observation period

OTHER2 trials

Sponsors

Grünenthal GmbH, University of Wisconsin, Madison

Conditions

Chronic PainEosinophilic EsophagitisLow Back Pain

Phase 3

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics

CompletedNCT00983385

Grünenthal GmbHChronic Pain, Low Back Pain

Start: 2009-09-30End: 2010-07-06Updated: 2019-01-15

Unknown Phase

Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis

CompletedNCT02775045

University of Wisconsin, MadisonEosinophilic Esophagitis

Start: 2016-08-30End: 2018-12-13Updated: 2019-01-30

Related Papers

Platelet association with leukocytes in active eosinophilic esophagitis

PLoS ONE2021-04-234 citations

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.

2012-05-0962 citations